The WACC of IND Swift Laboratories Ltd (INDSWFTLAB.NS) is 19.3%.
| Range | Selected | |
| Cost of equity | 18.00% - 21.30% | 19.65% |
| Tax rate | 30.00% - 30.00% | 30.00% |
| Cost of debt | 11.70% - 15.40% | 13.55% |
| WACC | 17.6% - 20.9% | 19.3% |
| Category | Low | High |
| Long-term bond rate | 6.9% | 7.4% |
| Equity market risk premium | 8.3% | 9.3% |
| Adjusted beta | 1.34 | 1.44 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 18.00% | 21.30% |
| Tax rate | 30.00% | 30.00% |
| Debt/Equity ratio | 0.04 | 0.04 |
| Cost of debt | 11.70% | 15.40% |
| After-tax WACC | 17.6% | 20.9% |
| Selected WACC | 19.3% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for INDSWFTLAB.NS:
cost_of_equity (19.65%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (1.34) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.